If validated in a larger independent cohort, women with an endometrial thickness >4 mm plus a positive urine CA125 test could be referred for definitive testing, while those with negative results are reassured without the need for unpleasant, painful, and anxiety-provoking tests, with large cost savings for health service providers. The gene discussed is MUC16; the disease is Anxiety.